ID   AGO3_HUMAN              Reviewed;         860 AA.
AC   Q9H9G7; B1ALI0; Q5TA55; Q9H1U6;
DT   14-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   27-SEP-2005, sequence version 2.
DT   28-JUN-2023, entry version 164.
DE   RecName: Full=Protein argonaute-3 {ECO:0000255|HAMAP-Rule:MF_03032};
DE            Short=Argonaute3 {ECO:0000255|HAMAP-Rule:MF_03032};
DE            Short=hAgo3;
DE            EC=3.1.26.n2 {ECO:0000269|PubMed:29040713};
DE   AltName: Full=Argonaute RISC catalytic component 3;
DE   AltName: Full=Eukaryotic translation initiation factor 2C 3 {ECO:0000255|HAMAP-Rule:MF_03032};
DE            Short=eIF-2C 3 {ECO:0000255|HAMAP-Rule:MF_03032};
DE            Short=eIF2C 3 {ECO:0000255|HAMAP-Rule:MF_03032};
GN   Name=AGO3; Synonyms=EIF2C3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Leukocyte;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   ASSOCIATION WITH MIRNA.
RX   PubMed=15260970; DOI=10.1016/j.molcel.2004.07.007;
RA   Meister G., Landthaler M., Patkaniowska A., Dorsett Y., Teng G., Tuschl T.;
RT   "Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs.";
RL   Mol. Cell 15:185-197(2004).
RN   [5]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16081698; DOI=10.1126/science.1115079;
RA   Pillai R.S., Bhattacharyya S.N., Artus C.G., Zoller T., Cougot N.,
RA   Basyuk E., Bertrand E., Filipowicz W.;
RT   "Inhibition of translational initiation by Let-7 MicroRNA in human cells.";
RL   Science 309:1573-1576(2005).
RN   [6]
RP   FUNCTION.
RX   PubMed=18771919; DOI=10.1016/j.cub.2008.07.072;
RA   Wu L., Fan J., Belasco J.G.;
RT   "Importance of translation and nonnucleolytic ago proteins for on-target
RT   RNA interference.";
RL   Curr. Biol. 18:1327-1332(2008).
RN   [7]
RP   INTERACTION WITH EIF4B; IMP8; PRMT5 AND TNRC6B.
RX   PubMed=19167051; DOI=10.1016/j.cell.2008.12.023;
RA   Weinmann L., Hoeck J., Ivacevic T., Ohrt T., Muetze J., Schwille P.,
RA   Kremmer E., Benes V., Urlaub H., Meister G.;
RT   "Importin 8 is a gene silencing factor that targets argonaute proteins to
RT   distinct mRNAs.";
RL   Cell 136:496-507(2009).
RN   [8]
RP   INTERACTION WITH APOBEC3F; APOBEC3G AND APOBEC3H.
RX   PubMed=22915799; DOI=10.1128/jvi.00595-12;
RA   Phalora P.K., Sherer N.M., Wolinsky S.M., Swanson C.M., Malim M.H.;
RT   "HIV-1 replication and APOBEC3 antiviral activity are not regulated by P
RT   bodies.";
RL   J. Virol. 86:11712-11724(2012).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH EDC4.
RX   PubMed=23064648; DOI=10.1038/nsmb.2400;
RA   Hu Q., Tanasa B., Trabucchi M., Li W., Zhang J., Ohgi K.A., Rose D.W.,
RA   Glass C.K., Rosenfeld M.G.;
RT   "DICER- and AGO3-dependent generation of retinoic acid-induced DR2 Alu RNAs
RT   regulates human stem cell proliferation.";
RL   Nat. Struct. Mol. Biol. 19:1168-1175(2012).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-825, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12] {ECO:0007744|PDB:5VM9}
RP   X-RAY CRYSTALLOGRAPHY (3.28 ANGSTROMS) IN COMPLEX WITH GUIDE RNA, GUIDE
RP   RNA-BINDING, FUNCTION, CATALYTIC ACTIVITY, METAL-BINDING SITES, MUTAGENESIS
RP   OF GLU-638, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=29040713; DOI=10.1093/nar/gkx916;
RA   Park M.S., Phan H.D., Busch F., Hinckley S.H., Brackbill J.A.,
RA   Wysocki V.H., Nakanishi K.;
RT   "Human Argonaute3 has slicer activity.";
RL   Nucleic Acids Res. 45:11867-11877(2017).
CC   -!- FUNCTION: Required for RNA-mediated gene silencing (RNAi). Binds to
CC       short RNAs such as microRNAs (miRNAs) and represses the translation of
CC       mRNAs which are complementary to them. Proposed to be involved in
CC       stabilization of small RNA derivates (siRNA) derived from processed RNA
CC       polymerase III-transcribed Alu repeats containing a DR2 retinoic acid
CC       response element (RARE) in stem cells and in the subsequent siRNA-
CC       dependent degradation of a subset of RNA polymerase II-transcribed
CC       coding mRNAs by recruiting a mRNA decapping complex involving EDC4.
CC       Possesses RNA slicer activity but only on select RNAs bearing 5'- and
CC       3'-flanking sequences to the region of guide-target complementarity
CC       (PubMed:29040713). {ECO:0000255|HAMAP-Rule:MF_03032,
CC       ECO:0000269|PubMed:18771919, ECO:0000269|PubMed:23064648,
CC       ECO:0000269|PubMed:29040713}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Endonucleolytic cleavage to 5'-phosphomonoester.;
CC         EC=3.1.26.n2; Evidence={ECO:0000269|PubMed:29040713};
CC   -!- SUBUNIT: Interacts with EIF4B, IMP8, PRMT5 and TNRC6B. Interacts with
CC       APOBEC3F, APOBEC3G and APOBEC3H. Interacts with EDC4.
CC       {ECO:0000255|HAMAP-Rule:MF_03032, ECO:0000269|PubMed:19167051,
CC       ECO:0000269|PubMed:22915799, ECO:0000269|PubMed:23064648}.
CC   -!- INTERACTION:
CC       Q9H9G7; Q6P2E9: EDC4; NbExp=2; IntAct=EBI-2267883, EBI-1006038;
CC       Q9H9G7; O15397: IPO8; NbExp=5; IntAct=EBI-2267883, EBI-358808;
CC       Q9H9G7; P53041: PPP5C; NbExp=2; IntAct=EBI-2267883, EBI-716663;
CC       Q9H9G7; Q8NDV7: TNRC6A; NbExp=5; IntAct=EBI-2267883, EBI-2269715;
CC       Q9H9G7; A6NIX2: WTIP; NbExp=3; IntAct=EBI-2267883, EBI-20730502;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, P-body {ECO:0000255|HAMAP-
CC       Rule:MF_03032, ECO:0000269|PubMed:16081698}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9H9G7-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9H9G7-2; Sequence=VSP_041084;
CC   -!- PTM: Ubiquitinated on surface-exposed lysines by a SCF-like E3
CC       ubiquitin-protein ligase complex containing ZSWIM8 during target-
CC       directed microRNA degradation (TDMD), a process that mediates
CC       degradation of microRNAs (miRNAs). Ubiquitination by the SCF-like E3
CC       ubiquitin-protein ligase complex containing ZSWIM8 leads to its
CC       subsequent degradation, thereby exposing miRNAs for degradation. ZSWIM8
CC       recognizes and binds AGO3 when it is engaged with a TDMD target.
CC       {ECO:0000250|UniProtKB:Q9UKV8}.
CC   -!- SIMILARITY: Belongs to the argonaute family. Ago subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03032}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK022827; BAB14262.1; -; mRNA.
DR   EMBL; AL139286; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL138787; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC025769; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS399.1; -. [Q9H9G7-1]
DR   CCDS; CCDS400.1; -. [Q9H9G7-2]
DR   RefSeq; NP_079128.2; NM_024852.3. [Q9H9G7-1]
DR   RefSeq; NP_803171.1; NM_177422.2. [Q9H9G7-2]
DR   RefSeq; XP_005270632.1; XM_005270575.3. [Q9H9G7-1]
DR   RefSeq; XP_011539184.1; XM_011540882.2.
DR   RefSeq; XP_016856012.1; XM_017000523.1. [Q9H9G7-1]
DR   RefSeq; XP_016856013.1; XM_017000524.1. [Q9H9G7-2]
DR   RefSeq; XP_016856014.1; XM_017000525.1.
DR   RefSeq; XP_016856015.1; XM_017000526.1. [Q9H9G7-2]
DR   RefSeq; XP_016856016.1; XM_017000527.1.
DR   PDB; 5VM9; X-ray; 3.28 A; A/C=1-860.
DR   PDBsum; 5VM9; -.
DR   AlphaFoldDB; Q9H9G7; -.
DR   SMR; Q9H9G7; -.
DR   BioGRID; 128177; 140.
DR   DIP; DIP-54486N; -.
DR   IntAct; Q9H9G7; 83.
DR   MINT; Q9H9G7; -.
DR   STRING; 9606.ENSP00000362287; -.
DR   GlyGen; Q9H9G7; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9H9G7; -.
DR   PhosphoSitePlus; Q9H9G7; -.
DR   BioMuta; AGO3; -.
DR   DMDM; 76803660; -.
DR   EPD; Q9H9G7; -.
DR   jPOST; Q9H9G7; -.
DR   MassIVE; Q9H9G7; -.
DR   MaxQB; Q9H9G7; -.
DR   PaxDb; Q9H9G7; -.
DR   PeptideAtlas; Q9H9G7; -.
DR   ProteomicsDB; 81320; -. [Q9H9G7-1]
DR   ProteomicsDB; 81321; -. [Q9H9G7-2]
DR   Antibodypedia; 31609; 201 antibodies from 30 providers.
DR   DNASU; 192669; -.
DR   Ensembl; ENST00000246314.10; ENSP00000246314.6; ENSG00000126070.20. [Q9H9G7-2]
DR   Ensembl; ENST00000373191.9; ENSP00000362287.3; ENSG00000126070.20. [Q9H9G7-1]
DR   GeneID; 192669; -.
DR   KEGG; hsa:192669; -.
DR   MANE-Select; ENST00000373191.9; ENSP00000362287.3; NM_024852.4; NP_079128.2.
DR   UCSC; uc001bzp.4; human. [Q9H9G7-1]
DR   AGR; HGNC:18421; -.
DR   CTD; 192669; -.
DR   DisGeNET; 192669; -.
DR   GeneCards; AGO3; -.
DR   HGNC; HGNC:18421; AGO3.
DR   HPA; ENSG00000126070; Low tissue specificity.
DR   MIM; 607355; gene.
DR   neXtProt; NX_Q9H9G7; -.
DR   OpenTargets; ENSG00000126070; -.
DR   PharmGKB; PA38329; -.
DR   VEuPathDB; HostDB:ENSG00000126070; -.
DR   eggNOG; KOG1041; Eukaryota.
DR   GeneTree; ENSGT00940000155256; -.
DR   HOGENOM; CLU_004544_4_3_1; -.
DR   InParanoid; Q9H9G7; -.
DR   OMA; RGRCYIH; -.
DR   OrthoDB; 3060088at2759; -.
DR   PhylomeDB; Q9H9G7; -.
DR   TreeFam; TF101510; -.
DR   PathwayCommons; Q9H9G7; -.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-203927; MicroRNA (miRNA) biogenesis.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-HSA-2559585; Oncogene Induced Senescence.
DR   Reactome; R-HSA-4086398; Ca2+ pathway.
DR   Reactome; R-HSA-426486; Small interfering RNA (siRNA) biogenesis.
DR   Reactome; R-HSA-426496; Post-transcriptional silencing by small RNAs.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-HSA-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-HSA-8853884; Transcriptional Regulation by VENTX.
DR   Reactome; R-HSA-8934593; Regulation of RUNX1 Expression and Activity.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8943723; Regulation of PTEN mRNA translation.
DR   Reactome; R-HSA-8948700; Competing endogenous RNAs (ceRNAs) regulate PTEN translation.
DR   Reactome; R-HSA-8986944; Transcriptional Regulation by MECP2.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-9022692; Regulation of MECP2 expression and activity.
DR   Reactome; R-HSA-9029569; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux.
DR   Reactome; R-HSA-9768778; Regulation of NPAS4 mRNA translation.
DR   SignaLink; Q9H9G7; -.
DR   BioGRID-ORCS; 192669; 11 hits in 1150 CRISPR screens.
DR   ChiTaRS; AGO3; human.
DR   GenomeRNAi; 192669; -.
DR   Pharos; Q9H9G7; Tbio.
DR   PRO; PR:Q9H9G7; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q9H9G7; protein.
DR   Bgee; ENSG00000126070; Expressed in buccal mucosa cell and 178 other tissues.
DR   ExpressionAtlas; Q9H9G7; baseline and differential.
DR   Genevisible; Q9H9G7; HS.
DR   GO; GO:0000794; C:condensed nuclear chromosome; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0036464; C:cytoplasmic ribonucleoprotein granule; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0000932; C:P-body; IEA:UniProtKB-SubCell.
DR   GO; GO:0016442; C:RISC complex; IDA:BHF-UCL.
DR   GO; GO:0070578; C:RISC-loading complex; IDA:BHF-UCL.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:BHF-UCL.
DR   GO; GO:0090624; F:endoribonuclease activity, cleaving miRNA-paired mRNA; IMP:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0035198; F:miRNA binding; IDA:BHF-UCL.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0004521; F:RNA endonuclease activity; IMP:UniProtKB.
DR   GO; GO:0003727; F:single-stranded RNA binding; IDA:BHF-UCL.
DR   GO; GO:0035196; P:miRNA processing; IMP:BHF-UCL.
DR   GO; GO:0035278; P:miRNA-mediated gene silencing by inhibition of translation; IDA:UniProtKB.
DR   GO; GO:0006402; P:mRNA catabolic process; IDA:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IEA:Ensembl.
DR   GO; GO:1901224; P:positive regulation of NIK/NF-kappaB signaling; IEA:Ensembl.
DR   GO; GO:0031054; P:pre-miRNA processing; IDA:BHF-UCL.
DR   GO; GO:0072091; P:regulation of stem cell proliferation; IMP:UniProtKB.
DR   GO; GO:0070922; P:RISC complex assembly; IDA:BHF-UCL.
DR   GO; GO:0010501; P:RNA secondary structure unwinding; IDA:BHF-UCL.
DR   CDD; cd02846; PAZ_argonaute_like; 1.
DR   CDD; cd04657; Piwi_ago-like; 1.
DR   Gene3D; 3.40.50.2300; -; 1.
DR   Gene3D; 2.170.260.10; paz domain; 1.
DR   Gene3D; 3.30.420.10; Ribonuclease H-like superfamily/Ribonuclease H; 1.
DR   HAMAP; MF_03032; AGO3; 1.
DR   InterPro; IPR028603; AGO3.
DR   InterPro; IPR014811; ArgoL1.
DR   InterPro; IPR032472; ArgoL2.
DR   InterPro; IPR032473; Argonaute_Mid_dom.
DR   InterPro; IPR032474; Argonaute_N.
DR   InterPro; IPR003100; PAZ_dom.
DR   InterPro; IPR036085; PAZ_dom_sf.
DR   InterPro; IPR003165; Piwi.
DR   InterPro; IPR045246; Piwi_ago-like.
DR   InterPro; IPR012337; RNaseH-like_sf.
DR   InterPro; IPR036397; RNaseH_sf.
DR   PANTHER; PTHR22891; EUKARYOTIC TRANSLATION INITIATION FACTOR 2C; 1.
DR   PANTHER; PTHR22891:SF3; PROTEIN ARGONAUTE-3; 1.
DR   Pfam; PF08699; ArgoL1; 1.
DR   Pfam; PF16488; ArgoL2; 1.
DR   Pfam; PF16487; ArgoMid; 1.
DR   Pfam; PF16486; ArgoN; 1.
DR   Pfam; PF02170; PAZ; 1.
DR   Pfam; PF02171; Piwi; 1.
DR   SMART; SM01163; DUF1785; 1.
DR   SMART; SM00949; PAZ; 1.
DR   SMART; SM00950; Piwi; 1.
DR   SUPFAM; SSF101690; PAZ domain; 1.
DR   SUPFAM; SSF53098; Ribonuclease H-like; 1.
DR   PROSITE; PS50821; PAZ; 1.
DR   PROSITE; PS50822; PIWI; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cytoplasm; Endonuclease;
KW   Hydrolase; Metal-binding; Nuclease; Phosphoprotein; Reference proteome;
KW   Ribonucleoprotein; RNA-binding; RNA-mediated gene silencing;
KW   Translation regulation; Ubl conjugation.
FT   CHAIN           1..860
FT                   /note="Protein argonaute-3"
FT                   /id="PRO_0000194061"
FT   DOMAIN          230..349
FT                   /note="PAZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00142"
FT   DOMAIN          518..819
FT                   /note="Piwi"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03032"
FT   REGION          530..567
FT                   /note="Interaction with guide RNA"
FT                   /evidence="ECO:0000305|PubMed:29040713"
FT   REGION          758..805
FT                   /note="Interaction with guide RNA"
FT                   /evidence="ECO:0000305|PubMed:29040713"
FT   BINDING         598
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /evidence="ECO:0000305|PubMed:29040713"
FT   BINDING         638
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /evidence="ECO:0000305|PubMed:29040713"
FT   BINDING         670
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /evidence="ECO:0000305|PubMed:29040713"
FT   BINDING         808
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /evidence="ECO:0000305|PubMed:29040713"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   MOD_RES         825
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..234
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_041084"
FT   MUTAGEN         638
FT                   /note="E->A: Loss of RNA slicer activity."
FT                   /evidence="ECO:0000269|PubMed:29040713"
FT   CONFLICT        25
FT                   /note="T -> A (in Ref. 1; BAB14262)"
FT                   /evidence="ECO:0000305"
FT   STRAND          27..40
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          47..52
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           60..73
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   TURN            76..79
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          88..96
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          122..126
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          128..132
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           136..139
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          141..143
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           159..174
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          181..184
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          192..194
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          197..210
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          213..226
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           231..238
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           253..263
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          267..271
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          279..285
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   TURN            290..292
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           309..315
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          328..332
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   TURN            334..337
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          338..342
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          345..347
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           359..369
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           373..386
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           389..391
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           393..397
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          407..413
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   TURN            423..425
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          452..456
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   TURN            460..462
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           465..481
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          491..495
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          498..501
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           502..512
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          518..523
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           529..539
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           550..554
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           558..571
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           581..583
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           586..589
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          592..600
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          611..618
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          620..623
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          626..633
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           643..657
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          658..660
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          664..669
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           677..692
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   TURN            693..695
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          702..707
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          716..719
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   TURN            721..723
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   TURN            726..729
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          735..737
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          739..742
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          744..752
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          764..771
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           777..788
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   STRAND          792..796
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           802..812
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           815..818
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           839..845
FT                   /evidence="ECO:0007829|PDB:5VM9"
FT   HELIX           851..853
FT                   /evidence="ECO:0007829|PDB:5VM9"
SQ   SEQUENCE   860 AA;  97360 MW;  6FF1277995E5322E CRC64;
     MEIGSAGPAG AQPLLMVPRR PGYGTMGKPI KLLANCFQVE IPKIDVYLYE VDIKPDKCPR
     RVNREVVDSM VQHFKVTIFG DRRPVYDGKR SLYTANPLPV ATTGVDLDVT LPGEGGKDRP
     FKVSIKFVSR VSWHLLHEVL TGRTLPEPLE LDKPISTNPV HAVDVVLRHL PSMKYTPVGR
     SFFSAPEGYD HPLGGGREVW FGFHQSVRPA MWKMMLNIDV SATAFYKAQP VIQFMCEVLD
     IHNIDEQPRP LTDSHRVKFT KEIKGLKVEV THCGTMRRKY RVCNVTRRPA SHQTFPLQLE
     NGQTVERTVA QYFREKYTLQ LKYPHLPCLQ VGQEQKHTYL PLEVCNIVAG QRCIKKLTDN
     QTSTMIKATA RSAPDRQEEI SRLVRSANYE TDPFVQEFQF KVRDEMAHVT GRVLPAPMLQ
     YGGRNRTVAT PSHGVWDMRG KQFHTGVEIK MWAIACFATQ RQCREEILKG FTDQLRKISK
     DAGMPIQGQP CFCKYAQGAD SVEPMFRHLK NTYSGLQLII VILPGKTPVY AEVKRVGDTL
     LGMATQCVQV KNVIKTSPQT LSNLCLKINV KLGGINNILV PHQRPSVFQQ PVIFLGADVT
     HPPAGDGKKP SIAAVVGSMD AHPSRYCATV RVQRPRQEII QDLASMVREL LIQFYKSTRF
     KPTRIIFYRD GVSEGQFRQV LYYELLAIRE ACISLEKDYQ PGITYIVVQK RHHTRLFCAD
     RTERVGRSGN IPAGTTVDTD ITHPYEFDFY LCSHAGIQGT SRPSHYHVLW DDNCFTADEL
     QLLTYQLCHT YVRCTRSVSI PAPAYYAHLV AFRARYHLVD KEHDSAEGSH VSGQSNGRDP
     QALAKAVQIH QDTLRTMYFA
//
